Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Roma

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Familial Cancer|November 14, 2014
First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological responseAnna Roma, Marco Maruzzo, Umberto Basso, et al.
Journal of Geriatric Oncology|January 30, 2014
Bi-weekly liposomal doxorubicin for advanced breast cancer in elderly women (≥ 70 years)Umberto Basso, Anna Roma, Antonella Brunello, et al.
Cell Reports|March 3, 2021
Glycosaminoglycan profiling in patients' plasma and urine predicts the occurrence of metastatic clear cell renal cell carcinomaFrancesco Gatto, Nicola Volpi, Helén Nilsson, et al.
Cell Reports|May 18, 2016
Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell CarcinomaFrancesco Gatto, Nicola Volpi, Helén Nilsson, et al.
Journal of Cancer Research and Clinical Oncology|November 9, 2015
Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experienceAntonella Brunello, Mario Domenico Rizzato, Marco Rastrelli, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironmentAnna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Journal of Cancer Research and Clinical Oncology|January 14, 2016
Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patientsAntonella Brunello, Andrea Fontana, Valeria Zafferri, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 19, 2025
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)Giulia Pasello, Giulia Pigato, Daniela Scattolin, et al.
Patient Preference and Adherence|February 17, 2022
Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of OncologyMario Caccese, Silvia Imbevaro, Alessandra Feltrin, et al.
American Journal of Respiratory and Critical Care Medicine|February 9, 2013
Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary diseaseMiguel-Angel Martínez-García, David de la Rosa Carrillo, Juan-Jose Soler-Cataluña, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Familial Cancer|November 14, 2014
First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological responseAnna Roma, Marco Maruzzo, Umberto Basso, et al.
Journal of Geriatric Oncology|January 30, 2014
Bi-weekly liposomal doxorubicin for advanced breast cancer in elderly women (≥ 70 years)Umberto Basso, Anna Roma, Antonella Brunello, et al.
Cell Reports|March 3, 2021
Glycosaminoglycan profiling in patients' plasma and urine predicts the occurrence of metastatic clear cell renal cell carcinomaFrancesco Gatto, Nicola Volpi, Helén Nilsson, et al.
Cell Reports|May 18, 2016
Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell CarcinomaFrancesco Gatto, Nicola Volpi, Helén Nilsson, et al.
Journal of Cancer Research and Clinical Oncology|November 9, 2015
Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experienceAntonella Brunello, Mario Domenico Rizzato, Marco Rastrelli, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironmentAnna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Journal of Cancer Research and Clinical Oncology|January 14, 2016
Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patientsAntonella Brunello, Andrea Fontana, Valeria Zafferri, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 19, 2025
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)Giulia Pasello, Giulia Pigato, Daniela Scattolin, et al.
Patient Preference and Adherence|February 17, 2022
Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of OncologyMario Caccese, Silvia Imbevaro, Alessandra Feltrin, et al.
American Journal of Respiratory and Critical Care Medicine|February 9, 2013
Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary diseaseMiguel-Angel Martínez-García, David de la Rosa Carrillo, Juan-Jose Soler-Cataluña, et al.
Pageof 3